Compositions and Methods for Treating the Eye
AssigneeJohnson & Johnson Surgical Vision, Inc.
InventorsWen-Hwa Ting Li, Khalid Mahmood, Ramine Parsa, Mingqi Bai, Kenneth T. Holeva
Life of this patent
Estimating the term…
Abstract
The present invention relates to compositions comprising one or more extracts and/or compounds having retinol-like activity and properties and methods of using the compositions to treat the eye.
Claims20
A composition for treating the eye comprising:
- i) a safe and effective amount of a compound and/or extract having retinol-like properties and/or benefits for use in treating the eye selected from one or more of:
- botanical extracts, or sources of extracts, from plants of the genus Acronychia, Licaria, Calendula and or Trigonella;
- bacterial extracts, or sources of extracts, of the genus Actinomyces;
- and compounds of Formula (I):
- wherein—
- the dotted lines represent simple or double bound;
- optionally one of the dotted line is a double bound;
- R1 represent an H, a carbonated chain, linear, cyclic, or branched, saturated or unsaturated, comprising from 1 to 20 carbon atoms;
- R2 represent a carbonated chain, linear, cyclic ringed, or branched, saturated or unsaturated, comprising from 1 to 20 carbon atoms;
- optionally a methyl (—CH3) or methylene (═CH2) moiety;
- a carbonated chain, linear, ringed, or branched, saturated or unsaturated, comprising from 1 to 20 carbon atoms;
- optionally from 1 to 10 carbon atoms;
- optionally 6 carbon atoms;
- optionally an aromatic moiety, optionally a phenyl moiety;
- optionally 2-methyl-prop-1,3-diene.
- ii) an ophthalmologically acceptable carrier.
A method for preventing or treating the symptoms associated with dry eye comprising the step of administering a composition comprising:
- i) a safe and effective amount of a compound and/or extract having retinol-like properties and/or benefits for use in treating dry eye selected from one or more of botanical extracts, or sources of extracts, from plants of the genus Acronychia, Licaria, Calendula and or Trigonella;
- bacterial extracts, or sources of extracts, of the genus Actinomyces;
- and compounds of Formula (I):
- wherein—
- the dotted lines represent simple or double bound;
- R1 represent an H, a carbonated chain, linear, cyclic, or branched, saturated or unsaturated, comprising from 1 to 20 carbon atoms;
- R2 represent a carbonated chain, linear, cyclic ringed, or branched, saturated or unsaturated, comprising from 1 to 20 carbon atoms;
- preferably a methyl (—CH3) or methylene (═CH2) moiety;
- a represent a carbonated chain, linear, ringed, or branched, saturated or unsaturated, comprising from 1 to 20 carbon atoms;
- and
- ii) optionally, an ophthalmologically acceptable carrier.
A method for treating a patient having decreased or low-level production/release/delivery/excretion of hyaluronic acid from and/or in the cornea comprising the step of topically administering to the eye the patient a composition comprising:
- i) a safe and effective amount of a compound and/or extract having retinol-like properties and/or benefits for use in treating dry eye selected from one or more of:
- botanical extracts, or sources of extracts, from plants of the genus Acronychia, Licaria, Calendula and or Trigonella;
- bacterial extracts, or sources of extracts, of the genus Actinomyces;
- and compounds of Formula (I):
- wherein—
- the dotted lines represent simple or double bound;
- preferably one of the dotted line is a double bound;
- R1 represent an H, a carbonated chain, linear, cyclic, or branched, saturated or unsaturated, comprising from 1 to 20 carbon atoms;
- R2 represent a carbonated chain, linear, cyclic ringed, or branched, saturated or unsaturated, comprising from 1 to 20 carbon atoms;
- preferably a methyl (—CH3) or methylene (═CH2) moiety;
- a represent a carbonated chain, linear, ringed, or branched, saturated or unsaturated, comprising from 1 to 20 carbon atoms;
- preferably from 1 to 10 carbon atoms;
- more preferably 6 carbon atoms;
- preferably an aromatic moiety, preferably a phenyl moiety;
- preferably 2-methyl-prop-1,3-diene.
- ii) optionally, an ophthalmologically acceptable carrier.
A composition for treating dry eye, comprising:
- i) a safe and effective amount of a compound and/or extract having retinol-like properties and/or benefits for use in treating dry eye selected from one or more of:
- botanical extracts, or sources of extracts, from plants of the genus Acronychia, Licaria, Calendula and or Trigonella;
- bacterial extracts, or sources of extracts, of the genus Actinomyces;
- and compounds of Formula (I):
- wherein—
- the dotted lines represent simple or double bound;
- preferably one of the dotted line is a double bound;
- R1 represent an H, a carbonated chain, linear, cyclic, or branched, saturated or unsaturated, comprising from 1 to 20 carbon atoms;
- R2 represent a carbonated chain, linear, cyclic ringed, or branched, saturated or unsaturated, comprising from 1 to 20 carbon atoms;
- preferably a methyl (—CH3) or methylene (═CH2) moiety;
- a represent a carbonated chain, linear, ringed, or branched, saturated or unsaturated, comprising from 1 to 20 carbon atoms;
- preferably from 1 to 10 carbon atoms;
- more preferably 6 carbon atoms;
- preferably an aromatic moiety, preferably a phenyl moiety;
- preferably 2-methyl-prop-1,3-diene;
- ii) one or more demulcents or soothing agents;
- and
- iii) optionally, an ophthalmologically acceptable carrier.
A method for promoting healing or increasing the rate of healing of wounds in and/or on the eye of a patient by administering compositions:
- i) a safe and effective amount of a compound and/or extract having retinol-like properties and/or benefits for use in treating dry eye selected from one or more of botanical extracts, or sources of extracts, from plants of the genus Acronychia, Licaria, Calendula and or Trigonella;
- bacterial extracts, or sources of extracts, of the genus Actinomyces;
- and compounds of Formula (I):
- wherein—
- the dotted lines represent simple or double bound;
- preferably one of the dotted line is a double bound;
- R1 represent an H, a carbonated chain, linear, cyclic, or branched, saturated or unsaturated, comprising from 1 to 20 carbon atoms;
- R2 represent a carbonated chain, linear, cyclic ringed, or branched, saturated or unsaturated, comprising from 1 to 20 carbon atoms;
- preferably a methyl (—CH3) or methylene (═CH2) moiety;
- a represent a carbonated chain, linear, ringed, or branched, saturated or unsaturated, comprising from 1 to 20 carbon atoms;
- preferably from 1 to 10 carbon atoms;
- more preferably 6 carbon atoms;
- preferably an aromatic moiety, preferably a phenyl moiety;
- preferably 2-methyl-prop-1,3-diene.
- ii) optionally, an ophthalmologically acceptable carrier.
Dependencies are inferred from the claim text.